Drug intelligence / Profile preview

modafinil + paracetamol

Development stage
Unknown
Lead developer
Teva Pharmaceutical Industries
Modality
Small Molecules
Administration
Oral, Intravenous, Rectal, Intramuscular
01

Overview

This is a combination of two active pharmaceutical ingredients: modafinil and paracetamol (also known as acetaminophen). Modafinil is a wakefulness-promoting agent primarily used to treat excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It acts as a central nervous system stimulant with mechanisms that are not fully understood but are believed to involve modulation of various neurotransmitter systems including dopamine reuptake inhibition. Paracetamol is an analgesic and antipyretic agent widely used for the relief of mild to moderate pain and fever; its mechanism involves inhibition of prostaglandin synthesis in the central nervous system. There is no evidence that this specific combination exists as a marketed fixed-dose product; however, both drugs may be co-administered in clinical practice for their respective indications.

Other names
modafinil and paracetamolmodafinil plus paracetamolmodafinil acetaminophen combination
02

Targets

DAT (Dopamine plasma membrane transport protein)NET (Norepinephrine Transporter)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on modafinil + paracetamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on modafinil + paracetamol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call